HLS Therapeutics (HLTRF) Stock Price, News & Analysis

Company Overview

HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded prescription therapies for unmet medical needs. With expertise in formulation and regulatory strategy, the company targets therapeutic areas that include central nervous system disorders, cardiovascular disease and pain management.

The company’s portfolio includes extended-release and novel dosage forms of established active compounds. Key offerings feature products for attention-deficit hyperactivity disorder, sleep disorders and neuropathic pain. HLS Therapeutics leverages strategic partnerships to deliver complex generics and specialty pharmaceuticals across multiple markets.

Founded in 2017 as a spin-out from Prometic Life Sciences, HLS Therapeutics maintains its corporate headquarters in Vaughan, Ontario, Canada, and a commercial office in Dublin, Ireland. Through licensing collaborations with leading global pharmaceutical companies, the firm distributes products in Canada, the United States and select European countries.

Under the leadership of its board‐level management team, HLS Therapeutics pursues a disciplined in-licensing model to bolster its product pipeline. The company continues to expand its specialty pharmaceutical footprint, aiming to address critical therapeutic gaps while seeking revenue-generating opportunities in regulated markets.

Key Stats

• Today's Range: $3.71 to $3.71
• 50-Day Range: $3.22 to $3.71
• 52-Week Range: $2.22 to $3.71
• Volume: N/A
• Average Volume: 1,868 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HLTRF Stock Analysis - Frequently Asked Questions

How have HLTRF shares performed this year?

HLS Therapeutics' stock was trading at $2.69 at the beginning of 2025. Since then, HLTRF shares have increased by 37.9% and is now trading at $3.71.

How do I buy shares of HLS Therapeutics?

Shares of HLTRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HLTRF
• CIK: N/A
• Web: www.hlstherapeutics.com
• Phone: 647-495-9000
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A